Surfactant replacement therapy.
Surfactant replacement therapy (SRT) has a proven role in the treatment of neonatal respiratory distress syndrome and severe meconium aspiration syndrome in infants, and may have a role in the treatment of pediatric patients with ARDS. Although newer delivery mechanisms and strategies are being studied, the classic surfactant administration paradigm consists of endotracheal intubation, surfactant instillation into the lung, and stabilization with mechanical ventilation followed by extubation when stable on low respiratory support. Currently, this surfactant administration procedure is bundled into Current Procedural Terminology (CPT) codes used when providing intensive care. A specific CPT code for surfactant administration is scheduled to be introduced in 2007. This article reviews clinical issues in SRT and the practice management considerations necessary to provide this care.
Stevens
Timothy P
TP
Golisano Children's Hospital at Strong, University of Rochester, Rochester, NY, USA.
Sinkin
Robert A
RA
D006801:Humans; D007231:Infant, Newborn; D007440:Intubation / Q000191:economics / Q000379:methods; D008471:Meconium Aspiration Syndrome / Q000188:drug therapy*; D020399:Practice Management / Q000191:economics; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D012121:Respiration, Artificial / Q000191:economics / Q000379:methods; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*
D011663:Pulmonary Surfactants